Fusion-oncogenes are associated with increased metastatic capacity and persistent disease in pediatric thyroid cancers

Fusion-oncogenes are associated with increased metastatic capacity and persistent disease in pediatric thyroid cancers is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Fusion-oncogenes are associated with increased metastatic capacity and persistent disease in pediatric thyroid cancers have?

Fusion-oncogenes are associated with increased metastatic capacity and persistent disease in pediatric thyroid cancers has 10 citations in the OpenAlex counts ScholarIQ stores.

When was Fusion-oncogenes are associated with increased metastatic capacity and persistent disease in pediatric thyroid cancers published?

Fusion-oncogenes are associated with increased metastatic capacity and persistent disease in pediatric thyroid cancers has 2021 year in the ScholarIQ index.

What is the open-access status of Fusion-oncogenes are associated with increased metastatic capacity and persistent disease in pediatric thyroid cancers?

Fusion-oncogenes are associated with increased metastatic capacity and persistent disease in pediatric thyroid cancers has green oa status in the ScholarIQ index.

What is the DOI of Fusion-oncogenes are associated with increased metastatic capacity and persistent disease in pediatric thyroid cancers?

The DOI for Fusion-oncogenes are associated with increased metastatic capacity and persistent disease in pediatric thyroid cancers is on the source record.

What is the OpenAlex record for Fusion-oncogenes are associated with increased metastatic capacity and persistent disease in pediatric thyroid cancers?

The OpenAlex for Fusion-oncogenes are associated with increased metastatic capacity and persistent disease in pediatric thyroid cancers is on the source record.